Search Results

FDA Approves Liquid Mycophenolate to Prevent Organ Rejections.

Subjects: KIDNEY transplantation; COMBINATION drug therapy; ADRENOCORTICAL hormonesUNITED States. Food & Drug Administration

• Source: Formulary Watch. 5/7/2024, p1-1. 1p.

Record details

Novartis Recalls Two Additional Lots of Sandimune.

Subjects: *PHARMACEUTICAL industry; DRUG efficacy; CLINICAL drug trials

• Source: Formulary Watch. 11/27/2023, p1-1. 1p.

Record details

Crystal Formation in Bottles Leads to Recall of Sandimmune.

Subjects: *PHARMACEUTICAL industry; GRAFT rejection; PATIENTS

• Source: Formulary Watch. 9/11/2023, p1-1. 1p.

Record details

FUROR OVER AN AIDS ANNOUNCEMENT Critics say a claim by French doctors is premature.

• Authors : Wallis, Claudia; Delaney, Patricia; Dowell, William

Subjects: AIDS treatment; CYCLOSPORINE; TRANSPLANTATION of organs, tissues, etc.DUFOIX, Georgina

• Source: TIME Magazine. 11/11/1985, Vol. 126 Issue 19, p77. 2p.

Record details

Lifesaver A new drug may improve the odds for successful transplants.

Subjects: CYCLOSPORINE; TRANSPLANTATION of organs, tissues, etc.; IMMUNE system

• Source: TIME Magazine. 10/30/1989, Vol. 134 Issue 18, p77. 1p.

Record details

Visualizing Relationships Between Data.

• Authors : Fireman, Jerry

Subjects: STRUCTURE-activity relationship in pharmacology; GLOBULINS; CYCLOSPORINE

• Source: Scientific Computing & Instrumentation. Feb2001, Vol. 18 Issue 3, p34. 4p. 1 Diagram, 2 Graphs.

Record details

Sandimmune/Neoral -- An Impressive Product Line By Any Standard.

Subjects: CYCLOSPORINE; IMMUNOSUPPRESSIVE agents; TRANSPLANTATION of organs, tissues, etc.SANDOZ AG SANDOZ AG SANDOZ AG 144229291 ; NOVARTIS AG 001221845 NOVARTIS AG NOVARTIS AG 001221845 001221845 NOVARTIS AG 001221845 NVS

• Source: Black Book - Novartis: Life Sciences on A Grand Scale. 1997, p19-20. 2p.

Record details

Pharmaceuticals: Competitive Threats To Sandimmune/Neoral.

Subjects: CYCLOSPORINE; IMMUNOSUPPRESSIVE agents; TRANSPLANTATION of organs, tissues, etc.NOVARTIS AG 001221845 NOVARTIS AG NOVARTIS AG 001221845 001221845 NOVARTIS AG 001221845 NVS; SANGSTAT Medical Corp. 605524719 SANGSTAT Medical Corp. SANGSTAT Medical Corp. 605524719 605524719 SANGSTAT Medical Corp. 605524719 SANG

• Source: Black Book - Novelties: Life Sciences on a Grand Scale. 1997, p21-23. 3p. 2 Charts, 1 Graph.

Record details

Sustained-release of Cyclosporin A pellets: preparation, in vitro release, pharmacokinetic studies and in vitro – in vivo correlation in beagle dogs.

• Authors : Jiang, Dongmei¹ (AUTHOR); Zeng, Jin¹ (AUTHOR); Zhu, Yuan¹ (AUTHOR)

Subjects: CONTROLLED release drugs; CYCLOSPORINE; IN vitro studies

• Source: Drug Development & Industrial Pharmacy. Jul2016, Vol. 42 Issue 7, p1174-1182. 9p.

Record details

New Regimen for Kidney Transplants.

Subjects: KIDNEY transplantation; TRANSPLANTATION of organs, tissues, etc.; CYCLOSPORINEUNITED States. Food & Drug Administration

• Source: FDA Consumer. Jul/Aug2003, Vol. 37 Issue 4, p4. 1/3p.

Record details